Jeffereis Comments on Ariad Pharmaceuticals, Inc. (ARIA) Following ASCO Abstracts
Tweet Send to a Friend
Jefferies analyst Eun K. Yang, Ph.D commented on Buy-rated Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) following the company's ASCO abstracts.Data from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
